In this study, we demonstrated that H-FABP but not BNP was higher in subjects with IR and Mets than in those without these conditions, suggesting that measurement of H-FABP might be suitable to predict the occurrence of myocardial damage in subjects with metabolic disorder. This evidence concerns the gene NPPB and Other metabolic disease.